| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |